|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net income | ||||
| Adjustments to reconcile net income to net cash used in operating activities | ||||
| Depreciation and amortization | ||||
| Provision for credit losses | ||||
| Noncash operating lease cost | ||||
| Net (accretion) amortization in securities (discounts) and premiums | ||||
| Capitalized servicing assets | ||||
| Capitalized Loan Trailing Fee Asset | ||||
| Additions to servicing asset | ||||
| Other | ||||
| Gain on sale of loans, net | ||||
| Originations of Strategic Program loans held-for-sale | ||||
| Proceeds from sale of Strategic Program loans held-for-sale | ||||
| (Recovery) impairment of SBA servicing asset | ||||
| Change in fair value of BFG | ||||
| Impairment (recovery) of SBA servicing asset | ||||
| Stock-based compensation expense | ||||
| Noncash change in credit enhancement asset | ||||
| Deferred income taxes | ||||
| Net changes in: | ||||
| Accrued interest receivable | ||||
| Other assets | ||||
| Accrued interest payable | ||||
| Operating lease liabilities | ||||
| Other liabilities | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Net increase in loans receivable | ||||
| Purchase of lease pools | ||||
| Proceeds from sale of loans and leases | ||||
| Investment in equity securities | ||||
| Distributions from BFG | ||||
| Proceeds from sales of loans held-for-investment | ||||
| Proceeds from sales of assets subject to operating leases | ||||
| Purchase of investment securities available-for-sale | ||||
| Purchase of bank premises and equipment, net | ||||
| Purchase of assets subject to operating leases | ||||
| Proceeds from maturities of securities available-for-sale | ||||
| Proceeds from maturities and paydowns of securities held-to-maturity | ||||
| Purchases of securities held-to-maturity | ||||
| (Purchase) redemption of FHLB stock | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Net increase in deposits | ||||
| Common stock repurchased | ||||
| Proceeds from exercise of stock options | ||||
| Payment of taxes related to net share settlement of equity awards | ||||
| Repayment of PPP Liquidity Facility | ||||
| Net cash provided by financing activities | ||||
| Net change in cash and cash equivalents | ||||
| Net change in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash, beginning of the period | ||||
| Cash, cash equivalents and restricted cash, end of the period | ||||
| Supplemental disclosures of cash flow information: | ||||
| Cash paid for income taxes | ||||
| Cash paid for interest | ||||
| Right-of-use assets obtained in exchange for operating lease liabilities (ASC 842 adoption effective January 1, 2022) | ||||
| Impact of current expected credit loss model (ASU 2016-13 adoption effective January 1, 2023) | ||||
| Supplemental disclosures of noncash investing and financing activities: | ||||
| Increase in BFG investment in exchange for shares of the Company's common stock | ||||
Loading...